Eloxx Pharmaceuticals Inc: Signed Global Licensing Partnership for Zkn-013 With Almirall Pharmaceuticals With $3M Upfront and up to $470M in Milestones
Eloxx Pharmicals Inc:与 Almirall Pharmicals 签署了 Zkn-013 全球许可合作伙伴关系,预付资金为 300 万美元,里程碑高达 4.7 亿美元
Eloxx Pharmaceuticals Inc: Signed Global Licensing Partnership for Zkn-013 With Almirall Pharmaceuticals With $3M Upfront and up to $470M in Milestones
Eloxx Pharmicals Inc:与 Almirall Pharmicals 签署了 Zkn-013 全球许可合作伙伴关系,预付资金为 300 万美元,里程碑高达 4.7 亿美元
使用浏览器的分享功能,分享给你的好友吧